Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of Bevacizumab, Temozolimide, Optune Gio Along with Emergence of New Class of Therapies | DelveInsight

New York, USA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of...
December 23, 2024 11:37 ET | Source: Research and Markets

Glioblastoma Multiforme Treatment (GBM) Market Research Report 2024-2030: Focus on Radiation Therapy, Surgery, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy

Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Treatment (GBM) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
April 26, 2024 04:35 ET | Source: Research and Markets

Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances in Treatment Protocols and Drug Developments

Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest report on the Glioblastoma pipeline...
December 24, 2021 07:13 ET | Source: Research and Markets

Global Glioblastoma Multiforme (GBM) Industry Landscape, 2030 - Featuring Genentech, Merck, VBL Therapeutics, Diffusion Pharma, Bayer, and More

Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme (GBM) - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. ...
December 13, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 by DelveInsight

Los Angeles, USA, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 | DelveInsight There are approximately 150+ key companies developing Glioblastoma...